Argenx is seeking a Director of HCP Launch Readiness and Vaccination Strategy to lead the commercialization of empasiprubart for Multifocal Motor Neuropathy (MMN). The ideal candidate will have extensive experience in pharmaceutical marketing, particularly with rare diseases, and will thrive in a dynamic, fast-paced environment focused on patient impact.
Base: $196,000.00 - $269,500.00 USD; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive benefits package
Must-have
Nice-to-have
Not specified